AN INFORMATIVE PROTOCOL FOR THE INVESTIGATION OF RECURRENT MISCARRIAGE - PRELIMINARY EXPERIENCE OF 500 CONSECUTIVE CASES

被引:297
作者
CLIFFORD, K
RAI, R
WATSON, H
REGAN, L
机构
[1] Department of Obstetrics and Gynaecology, St Mary's Hospital Medical School, London W2 1PG, Norfolk Place
基金
英国医学研究理事会;
关键词
ANTIPHOSPHOLIPID ANTIBODIES; EARLY PREGNANCY LOSS; HABITUAL ABORTION; LUTEINIZING HORMONE; RECURRENT MISCARRIAGE;
D O I
10.1093/oxfordjournals.humrep.a138703
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A total of 500 consecutive women (mean age 32.9 years; SD 5 years) presenting with a history of recurrent miscarriages (median 4; range 3-17) were investigated for the presence of antiphospholipid antibodies (APA), polycystic ovaries (PCO), hypersecretion of luteinizing hormone (LH) and chromosome abnormalities in order to detect an underlying cause of their pregnancy losses. All women had details of their previous reproductive history, investigations and treatment documented: 76% of the women had experienced only early pregnancy losses (miscarriage <13 weeks gestation); 32% had a history of subfertility; and significant parental chromosome rearrangements were present in 3.6% of couples. An ultrasound diagnosis of PCO was made in 56% of women, 58% of whom were demonstrated to hypersecrete LH, based on early morning urinary LH analysis. Circulating APA were found in 14% of women. An underlying cause of recurrent miscarriage-genetic, endocrine or autoimmune-was found in >50% of couples. Women in the latter two groups are being recruited to randomized treatment trials which are discussed.
引用
收藏
页码:1328 / 1332
页数:5
相关论文
共 33 条
[1]  
ADAMS J, 1985, LANCET, V2, P1375
[2]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[3]  
CARRERAS LO, 1988, LANCET, V2, P393
[4]  
CLIFFORD KA, 1992, J REPR FERT ABSTR SE, V10
[5]   HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME - CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS [J].
CONWAY, GS ;
HONOUR, JW ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1989, 30 (04) :459-470
[6]   SCREENING FOR LUPUS ANTICOAGULANT AND ANTICARDIOLIPIN ANTIBODIES IN WOMEN WITH FETAL LOSS [J].
CREAGH, MD ;
MALIA, RG ;
COOPER, SM ;
SMITH, AR ;
DUNCAN, SLB ;
GREAVES, M .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (01) :45-47
[7]  
FRANKS S, 1991, POLYCYSTIC OVARIES D, P99
[8]   INADEQUATE LUTEAL FUNCTION AND RECURRENT ABORTION - DIAGNOSIS AND TREATMENT OF LUTEAL PHASE DEFICIENCY [J].
FRITZ, MA .
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1988, 6 (02) :129-143
[9]   SYSTEMIC LUPUS-ERYTHEMATOSUS AND PREGNANCY [J].
GATENBY, PA .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (03) :261-278
[10]   ASSOCIATION OF MODERATE OBESITY WITH A POOR PREGNANCY OUTCOME IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME TREATED WITH LOW-DOSE GONADOTROPIN [J].
HAMILTONFAIRLEY, D ;
KIDDY, D ;
WATSON, H ;
PATERSON, C ;
FRANKS, S .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (02) :128-131